2013
DOI: 10.1016/s1474-4422(13)70002-4
|View full text |Cite
|
Sign up to set email alerts
|

Manifestations of HIV infection in the peripheral nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
70
1
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(78 citation statements)
references
References 130 publications
4
70
1
3
Order By: Relevance
“…The most widely accepted hypothesis of HIV-PN involves neuronal damage secondary to immune activation and release of cytokines [8,15] which could occur either in ART naive patients or those exposed to nucleoside reverse-transcriptase inhibitor (NRTI) therapy, one involving d4T [28]. However, neuropathy develops only in certain proportions of individuals treated with NRTIs [29].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The most widely accepted hypothesis of HIV-PN involves neuronal damage secondary to immune activation and release of cytokines [8,15] which could occur either in ART naive patients or those exposed to nucleoside reverse-transcriptase inhibitor (NRTI) therapy, one involving d4T [28]. However, neuropathy develops only in certain proportions of individuals treated with NRTIs [29].…”
Section: Discussionmentioning
confidence: 99%
“…Association of A/A homozygous genotype was also observed in HIV-PN as compared to HIV group (p < 0.05, OR = 6.5, CI = 2. [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. When LN group was segregated we found a significant association of IFN-c +874 A/A genotype in MB leprosy group (p < 0.05, OR = 8, CI = 3.1-21) and not in PB group as compared to HS.…”
Section: Ifn-c +874 T/a Polymorphismmentioning
confidence: 99%
See 1 more Smart Citation
“…Some antiretrovirals can cause neuropathy, and neurotoxicity may be a feature of concomitant medicines such as isoniazid for tuberculosis. 8,9 Drugs for neuropathic pain The IASP's Neuropathic Pain Special Interest Group (NeuPSIG) has recently undertaken a systematic review of medicines for neuropathic pain (Table).…”
Section: Primary Disease Managementmentioning
confidence: 99%
“…In the early stages of HIV infection, symptomatic neuropathy is seen in as few as 0.5 % of patients, but this increases dramatically as patients develop the full syndrome (Fuller et al 1993 ;Barohn et al 1993 ;So et al 1988 ;Hall et al 1991 ). Lange ( 1994 ), Gabbati et al ( 2013 ), and Centner et al ( 2013 ) provide a comprehensive review of the neuromuscular manifestations associated with HIV infection.…”
Section: Hiv Infectionmentioning
confidence: 99%